Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Physician Associates challenge outdated licensing rules to accelerate care, expand access, and ease the healthcare provider ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

While ADHD medications continue to reduce the risk for self-harm, injury, and car crashes, recent expanded prescribing ...

Delayed intracranial hemorrhage is uncommon in patients with mild traumatic brain injury receiving anticoagulant therapy, a study finds.

The American Heart Association’s PREVENT equations predict risk in subgroups of Asian and Hispanic people, a new study shows.